These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

875 related items for PubMed ID: 33628780

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J, Wang W, Song B, Song Y, Meng Z.
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [Abstract] [Full Text] [Related]

  • 5. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y, Zhang T, Qi L, Liu R, Liu G, Wang J, Song Q, Sun C.
    Biosci Rep; 2020 Jan 31; 40(1):. PubMed ID: 31950990
    [Abstract] [Full Text] [Related]

  • 6. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
    Gao L, Zhang L.
    BMC Cancer; 2021 Jul 23; 21(1):849. PubMed ID: 34301211
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
    Zhou RS, Zhang EX, Sun QF, Ye ZJ, Liu JW, Zhou DH, Tang Y.
    BMC Cancer; 2019 Aug 07; 19(1):779. PubMed ID: 31391008
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma.
    Tian Y, Yu M, Sun L, Liu L, Wang J, Hui K, Nan Q, Nie X, Ren Y, Ren X.
    J Comput Biol; 2020 Jul 07; 27(7):1067-1078. PubMed ID: 31750732
    [Abstract] [Full Text] [Related]

  • 18. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN, Ma L, Liu N.
    J Transl Med; 2018 Sep 27; 16(1):264. PubMed ID: 30261893
    [Abstract] [Full Text] [Related]

  • 19. Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis.
    Han P, Yang H, Li X, Wu J, Wang P, Liu D, Xiao G, Sun X, Ren H.
    Oncol Res; 2021 Sep 07; 28(7):715-729. PubMed ID: 33106209
    [Abstract] [Full Text] [Related]

  • 20. Construction of lncRNA TYMSOS/hsa-miR-101-3p/CEP55 and TYMSOS/hsa-miR-195-5p/CHEK1 Axis in Non-small Cell Lung Cancer.
    Ji L, Yang T, Liu M, Li J, Si Q, Wang Y, Liu J, Dai L.
    Biochem Genet; 2023 Jun 07; 61(3):995-1014. PubMed ID: 36352081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.